Urinary bladder masses: Techniques, imaging spectrum, and staging

Journal of Computer Assisted Tomography

Volumn 35, Issue 4, 2011, Pages 411-424

  Dighe, Manjiri K ^a   Bhargava, Puneet ^b   Wright, Jonathan ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b VA Puget Sound HCS   (United States)

Author keywords

bladder carcinoma; cystoscopy; imaging; transitional cell carcinoma; urinary bladder

Indexed keywords

COMPUTERIZED TOMOGRAPHY; ENDOSCOPY; TUMORS;

BENIGN LESION; BLADDER CARCINOMA; BLADDER NEOPLASMS; CYSTOSCOPY; DIFFUSION WEIGHTED IMAGING; MALIGNANT LESION; SPECTRA'S; TRANSITIONAL CELL CARCINOMA; URINARY BLADDER; VIRTUAL CYSTOSCOPIES;

MAGNETIC RESONANCE IMAGING;

GADOLINIUM;

ADENOCARCINOMA; AMYLOIDOSIS; BLADDER CANCER; BLADDER CARCINOMA; BLADDER TUMOR; CANCER STAGING; CARCINOSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DIFFUSION WEIGHTED IMAGING; FIBROMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

EID: 80051531400     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31821c2e9d     Document Type: Review

References (78)

1. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66:4-34. (Pubitemid 43049607)
2. Murphy W, Grignon D, Perlman E. Tumors of the Kidney, Bladder and Related UrinaryStructures. Washington, DC: American Registry of Pathology; 2004, 375-382, AFIP Atlas of Tumor Pathology; 4th series.
3. Witjes J, Redorta J, Jacqmin D, et al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol. 2010;57:607-614.
4. Witjes J, Douglass J. The role ofhexaminolevulinate fluorescence cystoscopy in bladder cancer. Nat Clin Pract Urol. 2007;4:542-549. (Pubitemid 47554987)
5. Stenzl A, Cowan N, De Santis M, et al. Update of the Clinical Guidelines of the European Association ofUrology on muscle-invasive and metastatic bladder carcinoma [in Spanish]. Actas Urol Esp. 2010;34:51-62.
6. Kawashima A, Vrtiska T, LeRoy A, et al. CTurography. Radiographics. 2004;24:(suppl 1):S35-S54; discussion S55-S58.
7. Sadow C, Silverman S, O'Leary M, et al. Bladder cancer detection with CT urography in an academic medical center. Radiology. 2008;249:195-202.
8. Ng C. Radiologic diagnosis and staging ofrenal and bladder cancer. Semin Roentgenol. 2006;41:121-138. (Pubitemid 43669026)
9. Hall T, MacVicar A. Imaging of bladder cancer. Imaging. 2001;13:1-10. (Pubitemid 32586688)
10. Barentsz J, Jager G, van Vierzen P, et al. Staging urinary bladder cancer after transurethral biopsy: value offast dynamic contrast-enhanced MR imaging. Radiology. 1996;201:185-193. (Pubitemid 26314386)
11. BeerA, Saar B, Link T, et al. Virtual endoscopy of the urinary tract from T(2)-weighted and gadolinium-enhanced T(1)-weighted MR urographic images [in German]. Rofo. 2001;173:997-1005. (Pubitemid 33101233)
12. Kim J, Ahn J, Park T, et al. Virtual cystoscopy of the contrast material-filled bladder in patients with gross hematuria. AJR Am JRoentgenol. 2002;179:763-768. (Pubitemid 34919595)
13. Bernhardt T, Rapp-Bernhardt U. Virtual cystoscopy of the bladder based on CT and MRI data. Abdom Imaging. 2001;26:325-332. (Pubitemid 32428962)
14. Lämmle M, Beer A, Settles M, et al. Reliability of MR imaging-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder. AJRAm J Roentgenol. 2002;178:1483-1488. (Pubitemid 34547837)
15. Abou-El-Ghar M, El-Assmy A, Refaie H, et al. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology. 2009;251:415-421.
16. Nikken J, Krestin G. MRI of the kidney-state of the art. Eur Radiol. 2007;17:2780-2793.
17. Matsuki M, Inada Y, Tatsugami F, et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol. 2007;17:201-204. (Pubitemid 46063045)
18. El-Assmy A, Abou-El-Ghar M, Refaie H, et al. Diffusion-weighted MR imaging in diagnosis of superficial and invasive urinary bladder carcinoma: a preliminary prospective study. Scientific World Journal. 2008;8:364-370. (Pubitemid 351669778)
19. El-Assmy A, Abou-El-Ghar M, Mosbah A, et al. Bladder tumour staging: comparison ofdiffusion-and T2-weighted MR imaging. EurRadiol. 2009;19:1575-1581.
20. Yoshida S, Koga F, Kawakami S, et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladdercancer. Urology. 2010;75:387-391.
21. Wong-You-Cheong J, Woodward P, Manning M, et al. From the archives of the AFIP: inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation. Radiographics. 2006;26:1847-1868.
22. Williams T, Wagner B, Corse W, et al. Fibroepithelial polyps of the urinary tract. Abdom Imaging. 2002;27:217-221. (Pubitemid 36460694)
23. Maya M, Slywotzky C. Urinary bladder leiomyoma: magnetic resonance imaging findings. Urol Radiol. 1992;14:197-199. (Pubitemid 23079175)
24. Metzdorf M, Schmidt J. Urinary bladder leiomyoma associated with pulmonary lymphangioleiomyomatosis. Urology. 2008;71:755.e753-e754.
25. Cornella J, Larson T, Lee R, et al. Leiomyoma of the female urethra and bladder: report oftwenty-three patients and review of the literature. Am J Obstet Gynecol. 1997;176:1278-1285. (Pubitemid 27291258)
26. Sundaram C, Rawal A, Saltzman B. Characteristics of bladder leiomyoma as noted on magnetic resonance imaging. Urology. 1998;52:1142-1143. (Pubitemid 28533395)
27. Wong-You-Cheong J, Woodward P, Manning M, et al. From the archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006;26:553-580. (Pubitemid 43515325)
28. Crecelius S, Bellah R. Pheochromocytoma of the bladder in an adolescent: sonographic and MR imaging findings. AJR Am J Roentgenol. 1995;165:101-103.
29. Doran F, Varinli S, Bayazit Y, et al. Pheochromocytoma of the urinary bladder. APMIS. 2002;110:733-736. (Pubitemid 36005840)
30. Purandare N, Sanghvi D, Jhambekar N. Pheochromocytoma of the urinary bladder. JUltrasoundMed. 2005;24:881-883. (Pubitemid 40734640)
31. Asbury WJ, Hatcher P, Gould H, et al. Bladder pheochromocytoma with ring calcification. Abdom Imaging. 1996;21:275-277. (Pubitemid 26127434)
32. Jalil N, Pattou F, Combemale F, et al. Effectiveness and limits of preoperative imaging studies forthe localisation ofpheochromocytomas and paragangliomas: a review of282 cases. French Association of Surgery (AFC), and the French Association of Endocrine Surgeons (AFCE). Eur JSurg. 1998;164:23-28.
33. Goswami A, Vaidyanathan S, Rao M, et al. Primary localised amyloidosis ofurinary bladder (a case report). JPostgradMed. 1984;30:253-254.
34. Strong G, Kelsey D, Hoch W. Primary amyloid disease of the bladder. JUrol. 1974;112:463-466.
35. American Cancer Society. Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society 2009.
36. Altekruse S, Kosary C, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
37. Zeegers M, Tan F, Dorant E, et al. The impact ofcharacteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89:630-639. (Pubitemid 30640110)
38. Steiner H, Bergmeister M, Verdorfer I, et al. Early results of bladder-cancer screening in a high-risk population ofheavy smokers. BJUInt. 2008;102:291-296. (Pubitemid 352019191)
39. Reuter V Pathology of bladder cancer: assessment ofprognostic variables andresponse to therapy. Semin Oncol. 1990;17:524-532. (Pubitemid 20358363)
40. Jimenez R, Gheiler E, Oskanian P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am JSurgPathol. 2000;24:980-987. (Pubitemid 30430485)
41. Langner C, Hutterer G, Chromecki T, et al. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma oftheupperurinarytract. VirchowsArch. 2006;448:604-611. (Pubitemid 44490558)
42. Moon W, Kim S, Cho J, et al. Calcified bladder tumors. CT features. Acta Radiol. 1992;33:440-443.
43. Pashos C, Botteman M, Laskin B, et al. Bladder cancer: epidemiology, diagnosis, andmanagement. CancerPract. 2002;10:311-322.
44. Reuter V Bladder. Risk and prognostic factors-a pathologist's perspective. Urol Clin North Am. 1999;26:481-492. (Pubitemid 29411680)
45. American Joint Committee on Cancer. AJCC Cancer Staging Manual. New York, NY: American Joint Committee on Cancer 2002.
46. Stein J, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. JClin Oncol. 2001;19:666-675. (Pubitemid 32120143)
47. MacVicar A. Bladder cancer staging. BJUInt. 2000; 86(suppl 1):111-122.
48. Morgan C, Calkins R, Cavalcanti E. Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate. Radiology. 1981;140:751-761. (Pubitemid 11054236)
49. Setty B, Holalkere N, Sahani D, et al. State-of-the-art cross-sectional imaging in bladder cancer. Curr Probl Diagn Radiol. 2007;36:83-96. (Pubitemid 46291635)
50. Maeda H, Kinukawa T, Hattori R, et al. Detection ofmuscle layer invasion with submillimeter pixel MR images: staging of bladder carcinoma. Magn Reson Imaging. 1995;13:9-19.
51. Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2005;184:121-127. (Pubitemid 40040915)
52. Fisher M, Hricak H, Tanagho E, et al. Imaging. Part II. Neoplasm. Radiology. 1985;157:471-477.
53. Rozanski T, Grossman H. Recent developments in the pathophysiology of bladder cancer. AJR Am J Roentgenol. 1994;163:789-792. (Pubitemid 24313133)
54. Yousem D, Gatewood O, Goldman S, et al. Synchronous and metachronous transitional cell carcinoma of the urinary tract: prevalence, incidence, andradiographic detection. Radiology. 1988;167:613-618.
55. Oldbring J, Glifberg I, Mikulowski P, et al. Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings. J Urol. 1989;141:1311-1313. (Pubitemid 19151784)
56. Kakizoe T, Tobisu K, Tanaka Y, et al. Development ofmultiple transitional cell carcinomas in the urinary tract. Jpn J Clin Oncol. 1991;21:110-114.
57. Baniel J, Vishna T. Primary transitional cell carcinoma in vesical diverticula. Urology. 1997;50:697-699. (Pubitemid 27494988)
58. Messing E, Catalona W. Urothelial tumors of the urinary tract. In: Walsh P, ed. Campbell's Urology. Philadelphia, PA: Saunders; 1998:2343-2348
59. Stein J, Skinner E, Boyd S, et al. Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of 2 cases. J Urol. 1993;149:588-589 (Pubitemid 23094063)
60. Ghoneim M. Nontransitional cell bladder cancer. In: Smith M, ed. Clinical Urology. Philadelphia, PA: Lippincott; 1994:680-681.
61. Wong J, Wasserman N, Padurean A. Bladder squamous cell carcinoma. Radiographics. 2004;24:855-860. (Pubitemid 38703250)
62. Narumi Y, Sato T, Hori S, et al. Squamous cell carcinoma of the uroepithelium: CTevaluation. Radiology. 1989;173:853-856. (Pubitemid 20007232)
63. Tekes A, Kamel I, Chan T, et al. MR imaging features of non-transitional cell carcinoma of the urinary bladder with pathologic correlation. AJR Am J Roentgenol. 2003;180:779-784. (Pubitemid 36237228)
64. Thali-Schwab C, Woodward P, Wagner B. Computed tomographic appearance ofurachal adenocarcinomas: review of25 cases. Eur Radiol. 2005;15:79-84. (Pubitemid 40109774)
65. Bates A, Baithun S. Secondary neoplasms of the bladder are histological mimics ofnontransitional cell primary tumours: clinicopathological and histological features of282 cases. Histopathology. 2000;36:32-40. (Pubitemid 30055420)
66. Blute M, Engen D, Travis W, et al. Primary signet ring cell adenocarcinoma of the bladder. J Urol. 1989;141:17-21. (Pubitemid 19028815)
67. Mukesh M, Cook N, Hollingdale A, et al. Small cell carcinoma of the urinary bladder: a 15-year retrospective review oftreatment and survival in the Anglian Cancer Network. BJUInt. 2009;103:747-752.
68. Cheng L, Pan C, Yang X, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer. 2004;101:957-962. (Pubitemid 39100428)
69. Sved P, Gomez P, Manoharan M, et al. Small cell carcinoma of the bladder. BJUInt. 2004;94:12-17. (Pubitemid 38980301)
70. Dahm P, Gschwend J. Malignant non-urothelial neoplasms of the urinary bladder: areview. Eur Urol. 2003;44:672-681. (Pubitemid 37542925)
71. Yilmaz E, Birlik B, Arican Z, et al. Carcinosarcoma of the renal pelvis and urinary bladder: a case report. Korean J Radiol. 2003;4:255-259. (Pubitemid 38569468)
72. Tekes A, Kamel I, SzarfG, et al. Carcinosarcoma of the urinary bladder: dynamic contrast-enhanced MR imaging with clinical and pathologic correlation. AJR Am J Roentgenol. 2003;181:139-142. (Pubitemid 36741474)
73. Bates A, Norton A, Baithun S. Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases. J Clin Pathol. 2000;53:458-461. (Pubitemid 30396468)
74. Rosenberg S, Diamond H, Jaslowitz B, et al. Lymphosarcoma: a review of1269 cases.Medicine (Baltimore). 1961;40:31-84.
75. Richmond J, Sherman R, Diamond H, et al. Renal lesions associated with malignant lymphomas. Am JMed. 1962;32:184-207.
76. Sufrin G, Keogh B, Moore R, et al. Secondary involvement of the bladder in malignant lymphoma. J Urol. 1977;118:251-253. (Pubitemid 8184341)
77. Yeoman L, Mason M, OlliffJ. Non-Hodgkin's lymphoma of the bladder-CT and MRI appearances. Clin Radiol. 1991;44:389-392.
78. Morichetti D, Mazzucchelli R, Lopez-Beltran A, et al. Secondary neoplasms of the urinary system and male genital organs. BJUInt. 2009;104:770-776.